Palisade Bio (PALI) Income from Continuing Operations (2010 - 2026)
Palisade Bio (PALI) reported Income from Continuing Operations of 10749000.0 for Q1 2026, down 365.12% year-over-year from 4054339.64 in Q1 2025, and down 7.67% on a QoQ basis from 9983000.0 in Q4 2025.
Palisade Bio (PALI) has 17 years of Income from Continuing Operations data on file, last reported at 10749000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 365.12% year-over-year to 10749000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26504000.0 (down 96.21% YoY) and the FY2025 annual result came in at 18066000.0, down 21.48% from the prior year.
- Income from Continuing Operations declined to 10749000.0 in Q1 2026 per PALI's latest filing, from 9983000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2311000.0 in Q1 2025 and bottomed at 10749000.0 in Q1 2026.
- The 5-year median for Income from Continuing Operations is 3612000.0 (2023), against an average of 4265000.0.
- The widest annual swing landed in 2022, when Income from Continuing Operations surged 89.33%; it then sank 365.12% in 2026.
- Tracing PALI's Income from Continuing Operations over 5 years: stood at 3851000.0 in 2022, then advanced by 18.0% to 3158000.0 in 2023, then declined by 7.19% to 3385000.0 in 2024, then tumbled by 194.92% to 9983000.0 in 2025, then dropped by 7.67% to 10749000.0 in 2026.
- Per Business Quant, the three latest PALI Income from Continuing Operations figures stand at 10749000.0 (Q1 2026), 9983000.0 (Q4 2025), and 2927000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -10.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.75 Mn |
| Dec 31, 2025 | -9.98 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Jun 30, 2025 | -2.85 Mn |
| Mar 31, 2025 | -2.31 Mn |
| Dec 31, 2024 | -3.39 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Jun 30, 2024 | -4.21 Mn |
| Mar 31, 2024 | -3.67 Mn |
| Dec 31, 2023 | -3.16 Mn |
| Sep 30, 2023 | -3.79 Mn |
| Jun 30, 2023 | -3.61 Mn |
| Mar 31, 2023 | -2.53 Mn |
| Dec 31, 2022 | -3.85 Mn |
| Sep 30, 2022 | -4.42 Mn |
| Jun 30, 2022 | -3.58 Mn |
| Mar 31, 2022 | -3.89 Mn |
| Dec 31, 2021 | -4.03 Mn |
| Sep 30, 2021 | -3.04 Mn |
| Jun 30, 2021 | -33.51 Mn |
| Mar 31, 2021 | -3.66 Mn |
| Dec 31, 2020 | -3.44 Mn |
| Sep 30, 2020 | -1.84 Mn |
| Jun 30, 2020 | -1.84 Mn |
| Mar 31, 2020 | -1.98 Mn |
| Dec 31, 2019 | -2.12 Mn |
| Sep 30, 2019 | -2.11 Mn |
| Jun 30, 2019 | -1.91 Mn |
| Mar 31, 2019 | -2.43 Mn |
| Dec 31, 2018 | -1.78 Mn |
| Sep 30, 2018 | -2.07 Mn |
| Jun 30, 2018 | -2.00 Mn |
| Mar 31, 2018 | -2.33 Mn |
| Dec 31, 2017 | -2.25 Mn |
| Sep 30, 2017 | -2.57 Mn |
| Jun 30, 2017 | -4.22 Mn |
| Mar 31, 2017 | -4.35 Mn |
| Dec 31, 2016 | -5.83 Mn |
| Sep 30, 2016 | -5.14 Mn |
| Jun 30, 2016 | -4.14 Mn |
| Mar 31, 2016 | -6.61 Mn |
| Dec 31, 2015 | -4.77 Mn |
| Sep 30, 2015 | -5.64 Mn |
| Jun 30, 2015 | -5.44 Mn |
| Mar 31, 2015 | -5.05 Mn |
| Dec 31, 2014 | -5.06 Mn |
| Sep 30, 2014 | -4.46 Mn |
| Jun 30, 2014 | -3.89 Mn |
| Mar 31, 2014 | -5.58 Mn |
| Dec 31, 2013 | -3.20 Mn |
| Sep 30, 2013 | -4.06 Mn |
| Jun 30, 2013 | -3.66 Mn |
| Mar 31, 2013 | -2.93 Mn |
| Dec 31, 2012 | -2.72 Mn |
| Sep 30, 2012 | -2.58 Mn |
| Jun 30, 2012 | -2.38 Mn |
| Mar 31, 2012 | -2.46 Mn |
| Dec 31, 2011 | -2.56 Mn |
| Sep 30, 2011 | -3.21 Mn |
| Jun 30, 2011 | -3.65 Mn |
| Mar 31, 2011 | -3.51 Mn |
| Dec 31, 2010 | -1.52 Mn |
| Sep 30, 2010 | -3.91 Mn |
| Jun 30, 2010 | -4.19 Mn |